These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9425951)

  • 1. Hepatitis B virus surface antigen and polymerase gene variants: potential virological and clinical significance.
    Locarnini SA
    Hepatology; 1998 Jan; 27(1):294-7. PubMed ID: 9425951
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatitis B viral mutation and its clinical significance].
    Asahina Y; Izumi N
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():167-74. PubMed ID: 15453309
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV variants and hepatitis B surface antigen mutants.
    Zuckerman AJ
    J Med Virol; 2006; 78 Suppl 1():S1-2. PubMed ID: 16622868
    [No Abstract]   [Full Text] [Related]  

  • 4. Viral and clinical factors associated with surface gene variants among hepatitis B virus carriers.
    Roque-Afonso AM; Férey MP; Ly TD; Graube A; Costa-Faria L; Samuel D; Dussaix E
    Antivir Ther; 2007; 12(8):1255-63. PubMed ID: 18240865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus escape mutants induced by antiviral therapy.
    Sheldon J; Soriano V
    J Antimicrob Chemother; 2008 Apr; 61(4):766-8. PubMed ID: 18218641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B escape mutant reactivation in a renal transplant patient.
    Le Pendeven C; Cuzon G; Fontaine H; Zatla F; Schneider V; Amiel C; Khayat R; Nicolas JC; Soussan P
    J Clin Virol; 2007 Sep; 40(1):74-6. PubMed ID: 17652016
    [No Abstract]   [Full Text] [Related]  

  • 7. Designing clinical development programs for anti-hepatitis B virus drugs.
    Brown NA
    Methods Mol Med; 2004; 96():499-537. PubMed ID: 14762289
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis B virus genetic diversity.
    Echevarría JM; Avellón A
    J Med Virol; 2006; 78 Suppl 1():S36-42. PubMed ID: 16622876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants of hepatitis B virus and their clinical relevance.
    Baumert TF; Barth H; Blum HE
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):95-108. PubMed ID: 15756149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lamivudine treatment consensus from relative experts].
    Lamivudine Clinical Practice Group
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):157-8. PubMed ID: 12108391
    [No Abstract]   [Full Text] [Related]  

  • 11. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection.
    Milich D; Liang TJ
    Hepatology; 2003 Nov; 38(5):1075-86. PubMed ID: 14578844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact.
    Weber B
    J Clin Virol; 2005 Feb; 32(2):102-12. PubMed ID: 15653412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene.
    Weber B
    Expert Rev Mol Diagn; 2005 Jan; 5(1):75-91. PubMed ID: 15723594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and virological features of non-breakthrough and severe exacerbation due to lamivudine-resistant hepatitis B virus mutants.
    Suzuki F; Akuta N; Suzuki Y; Sezaki H; Arase Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kobayashi M; Matsuda M; Satoh J; Watahiki S; Kumada H
    J Med Virol; 2006 Mar; 78(3):341-52. PubMed ID: 16419116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations affecting the replication capacity of the hepatitis B virus.
    Sheldon J; Rodès B; Zoulim F; Bartholomeusz A; Soriano V
    J Viral Hepat; 2006 Jul; 13(7):427-34. PubMed ID: 16792535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant hepatitis B associated with a specific insertion in the basal core promoter region of hepatitis B virus DNA after immunosuppressive treatment.
    Gérolami R; Henry M; Borentain P; Colson P; Botta D; Tamalet C
    Clin Infect Dis; 2005 Feb; 40(4):e24-7. PubMed ID: 15712066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo infection in a renal transplant recipient caused by novel mutants of hepatitis B virus despite the presence of protective anti-hepatitis B surface antibody.
    Lu M; Lorentz T
    J Infect Dis; 2003 Apr; 187(8):1323-6. PubMed ID: 12696014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen.
    Petit MA; Buffello-Le Guillou D; Roche B; Dussaix E; Duclos-Vallée JC; Féray C; Samuel D
    J Med Virol; 2001 Nov; 65(3):493-504. PubMed ID: 11596084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus genetic diversity and its impact on diagnostic assays.
    Hollinger FB
    J Viral Hepat; 2007 Nov; 14 Suppl 1():11-5. PubMed ID: 17958637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of hepatitis B].
    Telegdy L
    Orv Hetil; 2004 Nov; 145(45):2293-6. PubMed ID: 15573894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.